Archive for June, 2017

  • aside

    Isofol has initiated five additional study sites in the ISO-CC-005 study in which Modufolin® is evaluated in colorectal cancer

    Isofol Medical AB (publ) announced today that the last one of five additional study sites was initiated in Greece and…

    by